DNDi has a global team of around 200 committed staff and close consultants. Our diverse team represents more than 30 nationalities and brings together experienced professionals with backgrounds in academia, non-profit organizations, the private sector, and public institutions.
Our headquarters are in Geneva, Switzerland. We have regional offices in Brazil, Democratic Republic of Congo, India, Japan, Kenya, Malaysia, South Africa, and the United States of America.
Board Of Directors
The Board of Directors is made up of 10 to 13 members including a patient advocate, with each of six Founding Partners nominating one board member. In principle, Board members serve for a term of four years. The Board of Directors elects the Chair, the Secretary and the Treasurer among its members.
Our regional entities are also governed by Boards of Directors.
Scientific Advisory Commitee
The Scientific Advisory Committee (SAC) is composed of not less than five prominent scientists with expertise in various scientific disciplines relating to drug discovery and development, and/or to the specific reality of neglected diseases and patients. The committee operates independently of the Board of Directors.
DNDi‘s leadership implements the R&D strategy, manages the global portfolio, allocates resources, fundraises, and advocates.
Friends of DNDi
DNDi’s Board of Directors has established Friends of DNDi to recognize select individuals who support DNDi’s mission and vision by engaging global influencers, policymakers and supporters to help DNDi succeed in reaching its objectives.
Gender Equality, Diversity, and Inclusion
Gender equality in the workplace is a human right and critical to the performance and effectiveness of DNDi. DNDi will take all reasonable steps to ensure that individuals are treated equally and fairly.